茚萘洛尔在合并慢性支气管哮喘的高血压患者中的潜在应用
[Potential use of indenolol in hypertensive patients with chronic bronchial asthma].
作者信息
Della Toffola A, Galietti F, Giorgis G E, Miravalle C, Oliaro A, Palazzo F, Scappaticci E
出版信息
Minerva Med. 1986 Oct 13;77(39):1819-21.
PMID:3534631
Abstract
The data are reported on a double blind clinical experiment using indenolol on a group of asthmatic hypertensives. The drug revealed a satisfactory anti-hypertensive action in the absence of any significantly bronchoconstrictive effect. The orciprenaline test performed at the end of the experiment showed that the drug does not reduce the availability of beta 2 bronchial receptors vis-à-vis the beta 2 stimulants.
摘要
这些数据来自一项在一组哮喘型高血压患者中使用吲哚洛尔的双盲临床试验报告。该药物在没有任何明显支气管收缩作用的情况下显示出令人满意的抗高血压作用。实验结束时进行的奥西那林试验表明，相对于β2兴奋剂，该药物不会降低β2支气管受体的可用性。
Zotero 插件